Introduction {#s1}
============

A cell\'s survival depends on its ability to respond appropriately to its extracellular environment. An appropriate response often depends not only on the presence or absence of a signal, but also on its magnitude and duration. Many signaling pathways utilize protein kinases, which commonly regulate downstream transcription factors through phosphorylation. Phosphorylation can affect the activity, stability, or subcellular localization of transcription factors ([@pbio.0000028-Cohen1]). Multisite phosphorylation of a protein permits not only the binary combination of the effects of each phosphorylation event, but also the emergence of more complex properties, such as signal integration ([@pbio.0000028-Cohen1]), switch-like behavior ([@pbio.0000028-Ferrell1]; [@pbio.0000028-Nash1]), and kinetic proofreading ([@pbio.0000028-McKeithan1]). Although many proteins are phosphorylated on multiple sites, the biological significance of such phosphorylation is in most cases unclear.

When starved for inorganic phosphate, Saccharomyces cerevisiae induces a program of gene expression that includes a phosphate permease, Pho84 (NP_013583); a secreted acid phosphatase, Pho5 (NP_009651); and proteins involved in phosphate storage ([@pbio.0000028-Oshima1]; [@pbio.0000028-Ogawa2]). Induction of the phosphate-responsive gene expression program is controlled by the transcription factor Pho4 (NP_116692) ([@pbio.0000028-Oshima2]). Activity and localization of Pho4 are regulated in response to phosphate availability through phosphorylation by the nuclear cyclin--CDK (cyclin-dependent kinase) complex, Pho80--Pho85 (NP_014642 and NP_015294) ([@pbio.0000028-OaNeill1]; [@pbio.0000028-Komeili1]). Pho4 is unphosphorylated, nuclear-localized, and active when yeast cells are starved for phosphate, but is phosphorylated, cytoplasmic, and inactive when cells are grown in phosphate-rich medium ([@pbio.0000028-Kaffman1]; [@pbio.0000028-OaNeill1]). Pho4 is phosphorylated by Pho80--Pho85 on four functionally important serine residues ([@pbio.0000028-OaNeill1]) ([Figure 1](#pbio.0000028-g001){ref-type="fig"}A). Together, phosphorylation of sites 2 and 3 results in export of Pho4 from the nucleus by promoting its interaction with the export receptor Msn5 (NP_010622) ([@pbio.0000028-Kaffman2]). Phosphorylation of site 4 inhibits nuclear import of Pho4 by impairing its binding to the import receptor Pse1 (NP_014039) ([@pbio.0000028-Kaffman2]). Phosphorylation of Pho4 also regulates its transcriptional activity within the nucleus; phosphorylation of site 6 inhibits the binding of Pho4 to Pho2 (NP_010177), a transcription factor essential for the induction of many phosphate-responsive genes ([@pbio.0000028-Komeili1]).

![Whole-Genome Expression DNA Microarrays of *PHO4^SA1234WT6^* and *PHO4^SA1234PA6^* Strains\
(A) Schematic showing phosphorylation sites ([@pbio.0000028-OaNeill1]), the transcriptional activation domain ([@pbio.0000028-McAndrew1]), the nuclear localization sequence ([@pbio.0000028-Kaffman2]), the Pho2-binding domain ([@pbio.0000028-Hirst1]), and the DNA-binding domain of Pho4 ([@pbio.0000028-Ogawa1]). Pho4 is phosphorylated on five sites (referred to as sites 1, 2, 3, 4, and 6) by Pho80--Pho85 ([@pbio.0000028-OaNeill1]). Site 1 is phosphorylated inefficiently in vivo and in vitro, and no functional consequence has been attributed to its phosphorylation ([@pbio.0000028-OaNeill1]; [@pbio.0000028-Komeili1]).\
(B) Color scheme denoting the fold induction/repression for all of the microarray experiments.\
(C) Expression of phosphate-responsive genes in strains containing Pho4^SA1234WT6^ and Pho4^SA1234PA6^ grown in high-phosphate medium. Cy5-labeled samples are colored red, and Cy3-labeled samples are colored green. The percent of induction of each gene in the Pho4^SA1234WT6^ strain compared to its maximal induction in the Pho4^SA1234PA6^ strain is presented on the right. Several phosphate-responsive genes (*PHO5*, *PHO8*, *PHO11*, and *PHO12*) share large regions of homology. Cross-hybridization leads to similar response profiles even though the genes probably respond differently.](pbio.0000028.g001){#pbio.0000028-g001}

The kinetics by which Pho80--Pho85 phosphorylates Pho4 could lead to the accumulation of different Pho4 phosphoforms in vivo. In vitro, on average only two of the four functionally relevant phosphorylatable serine residues are phosphorylated on a single molecule of Pho4 during one binding interaction, between Pho80--Pho85 and an unphosphorylated Pho4 dimer ([@pbio.0000028-Jeffery1]). Additionally, in vitro Pho80--Pho85 shows dramatic site preference; site 6 on Pho4 is phosphorylated approximately 50% of the time during any single phosphorylation event ([@pbio.0000028-Jeffery1]). Together, this leads to phosphorylation of site 6 before phosphorylation of both sites 2 and 3 approximately 90% of the time ([@pbio.0000028-Jeffery1]). These in vitro characteristics of Pho4 phosphorylation by Pho80--Pho85 suggest that a partially phosphorylated form of Pho4 predominately phosphorylated on site 6 may accumulate in vivo when Pho80--Pho85 is partially active.

We wished to determine whether partially phosphorylated forms of Pho4 accumulate under physiological conditions and whether such forms of Pho4 have activity that is different from Pho4, that is, either completely phosphorylated or unphosphorylated. We demonstrated a mutant form of Pho4 that is partially phosphorylated efficiently activates transcription of a subset of phosphate-responsive genes. We also uncovered a physiological growth condition in which only a subset of the phosphate-responsive genes is induced significantly. The differential gene expression observed under this growth condition correlates with the appearance of a partially phosphorylated form of Pho4 that is phosphorylated predominately on site 6.

Results {#s2}
=======

Regulation of Either the Activity or Nuclear Localization of Pho4 Is Sufficient to Prevent Induction of *PHO5*, but Not *PHO84*, in High-Phosphate Medium {#s2a}
---------------------------------------------------------------------------------------------------------------------------------------------------------

Motivated by our in vitro observations that Pho80--Pho85 preferentially phosphorylates Pho4 on site 6, we wished to systematically explore the transcriptional properties of Pho4 phosphorylated only on site 6. Our previous studies had demonstrated that this form of Pho4 was localized to the nucleus but could not efficiently activate transcription of *PHO5* ([@pbio.0000028-Komeili1]). We wished to determine whether Pho4 phosphorylated only on site 6 could activate transcription of any phosphate-responsive genes.

To address this question, we made use of a mutant form of Pho4 that can only be phosphorylated on site 6; this mutant contains serine-to-alanine substitutions at phosphorylation sites 1, 2, 3, and 4 (referred to as SA1234). Pho4^SA1234WT6^ is localized to the nucleus and phosphorylated on site 6 in high-phosphate conditions, but it cannot efficiently activate transcription of *PHO5* ([@pbio.0000028-Komeili1]). We compared the transcriptional properties of Pho4^SA1234WT6^ to those of a second mutant form of Pho4, which is refractory to phosphorylation because it has serine-to-alanine substitutions at sites 1, 2, 3, and 4 of Pho4 and a proline-to-alanine substitution at site 6 (referred to as SA1234PA6; it is necessary to mutate the proline because the serine at site 6 is required for the full induction of phosphate-responsive genes) ([@pbio.0000028-Komeili1]). Pho4^SA1234PA6^ is localized to the nucleus and unphosphorylated on site 6 in high-phosphate conditions and efficiently activates transcription of *PHO5* ([@pbio.0000028-Komeili1]). Strains expressed both Pho4^SA1234PA6^ and Pho4^SA1234WT6^ at levels that were indistinguishable from wild-type Pho4 expression as determined by fluorescence-activated cell sorting (FACS) and fluorescence microscopy (see the Supplementary Microscopy Section below).

Yeast strains expressing Pho4^SA1234PA6^ and Pho4^SA1234WT6^ were analyzed by whole-genome expression profiling using cDNA microarrays. The gene expression profile of the *PHO4^SA1234PA6^* strain grown in high-phosphate medium was very similar to the profile observed for a wild-type strain grown in no-phosphate medium, where Pho4 is completely unphosphorylated; all phosphate-responsive genes, including *PHO5*, are induced ([Figure 1](#pbio.0000028-g001){ref-type="fig"}C) ([@pbio.0000028-Ogawa2]). In contrast, the *PHO4^SA1234WT6^* strain grown in high-phosphate medium expressed only a subset of genes normally induced in no-phosphate medium ([Figure 1](#pbio.0000028-g001){ref-type="fig"}C). The 20 phosphate-responsive genes examined largely fell into two classes when we compared the percent induction of each phosphate-responsive gene in the *PHO4^SA1234WT6^* strain to its maximal induction in the *PHO4^SA1234PA6^* strain. Four genes were induced less than 11%, whereas 15 genes were induced more than 40% ([Figure 1](#pbio.0000028-g001){ref-type="fig"}C). The class induced less than 11% was comprised mainly of phosphate-responsive phosphatases, whereas the class induced more than 40% consisted mainly of genes involved in phosphate storage, mobilization, and transport. From the first category, we chose to analyze *PHO5* (encoding a secreted acid phosphatase) further because it was both highly induced in no-phosphate medium and well characterized. From the second category, we chose to analyze *PHO84* (encoding a high affinity phosphate transporter) because it was induced over 100-fold in both the *PHO4^SA1234WT6^* and *PHO4^SA1234PA6^*strains.

Physiological Conditions That Cause Differential Phosphorylation of Pho4 {#s2b}
------------------------------------------------------------------------

Our observations with the Pho4 mutants led us to ask whether there exist physiologically relevant conditions in which partially phosphorylated Pho4 accumulates in the nucleus and causes differential gene expression. We predicted that as the extracellular phosphate concentration drops, Pho80--Pho85 would become partially inactivated, and because of the kinetic properties of Pho80--Pho85, a nuclear pool of Pho4 phosphorylated on site 6 (but not on sites 2 and 3) would accumulate. We anticipated that only at much lower concentrations of phosphate would a nuclear pool of completely unphosphorylated Pho4 build up and activate transcription of all phosphate-responsive genes.

To test these predictions, we grew cells in medium containing different levels of phosphate (0, 50, 100, 300, and 10,000 μM) and monitored localization of a Pho4--GFP (green fluorescent protein) fusion protein and transcription of *PHO5* and *PHO84*. We observed three different responses to different phosphate conditions. First, the high-phosphate response occurs at extracellular phosphate concentrations greater than 300 μM phosphate. Pho4 is cytoplasmic, and *PHO5* and *PHO84* are expressed at only basal levels under these conditions ([Figure 2](#pbio.0000028-g002){ref-type="fig"}A and [2](#pbio.0000028-g002){ref-type="fig"}B). Second, the no-phosphate response occurs when there is no phosphate in the medium. Pho4 is nuclear, and *PHO5* and *PHO84* are expressed maximally under these conditions ([Figure 2](#pbio.0000028-g002){ref-type="fig"}A and [2](#pbio.0000028-g002){ref-type="fig"}B). Third, the intermediate-phosphate response occurs at extracellular phosphate concentrations less than 100 μM phosphate and greater than no phosphate. Pho4 is nuclear, but under these conditions there is only approximately 10% of maximal expression of *PHO5*, while there is approximately 50% of maximal expression of *PHO84* ([Figure 2](#pbio.0000028-g002){ref-type="fig"}A and [2](#pbio.0000028-g002){ref-type="fig"}B).

![Growth of Yeast Cells in Intermediate-Phosphate Medium Leads to Differential Phosphorylation of Pho4 and Differential Expression of *PHO5* and *PHO84*\
(A) Fluorescence microscopy of yeast cells containing Pho4--GFP grown in no, 50 μM, 100 μM (intermediate \[int\]), 300 μM, or 10,000 μM (high) phosphate medium.\
(B) Quantitation of RNA levels by Northern blot analysis of *PHO84*, *PHO5*, and *ACT1* in wild-type cells grown in medium containing different concentrations of phosphate.\
(C) Quantitation of RNA levels by Northern blot analysis of *PHO84*, *PHO5*, and *ACT1*, in wild-type cells grown for 1, 2, or 5 h in intermediate-phosphate medium.\
(D) Expression of genes in the phosphate-responsive cluster ([@pbio.0000028-Carroll1]) for a wild-type strain grown in intermediate- or no-phosphate medium compared to wild-type cells grown in high-phosphate medium. Cy5 and Cy3 samples are colored red and green, respectively. The percent of induction of each gene in intermediate-phosphate medium compared to its maximal induction in no-phosphate medium is presented on the right.\
(E) Analysis of Pho4 protein and phosphorylation by Western blotting for wild-type cells grown in no-, intermediate-, and high-phosphate medium. Samples were probed with phosphopeptide antibodies specific to sites 2, 3, and 6 of Pho4 and by a polyclonal antibody that recognizes Pho4.\
(F) Quantitation of RNA levels by Northern blot analysis of *PHO84*, *PHO5*, and *ACT1*, in a *PHO4^WT1234SD6^* strain.](pbio.0000028.g002){#pbio.0000028-g002}

To further characterize the properties of the intermediate-phosphate response, we examined the time and concentration dependence of *PHO5* and *PHO84* expression. Differential gene induction was observed in medium containing less than approximately 150 μM phosphate and more than 1 μM phosphate medium (data not shown). To confirm that the differential transcriptional response of *PHO5* and *PHO84* observed in intermediate-phosphate medium is not a kinetic artifact, we monitored the amount of *PHO5* and *PHO84* mRNA over several hours ([Figure 2](#pbio.0000028-g002){ref-type="fig"}C). The expression pattern of *PHO5* and *PHO84* was stable over a range of both time and external phosphate concentration, indicating that the intermediate-phosphate response is robust. After 4--6 h, cells adapted to intermediate-phosphate medium and Pho4 was relocalized to the cytoplasm (data not shown).

Whole-genome expression profiling of cells grown in intermediate-phosphate medium was used to assess the number of phosphate-responsive genes that behave like *PHO5* or *PHO84*. Genes fell into two classes when we compared the induction of each phosphate-responsive gene in intermediate-phosphate medium to its induction in no-phosphate medium ([Figure 2](#pbio.0000028-g002){ref-type="fig"}D). These two classes were similar to the two classes observed when we compared the strain expressing Pho4^SA1234WT6^ to the strain expressing Pho4^SA1234PA6^ ([Figure 2](#pbio.0000028-g002){ref-type="fig"}D). This was anticipated because both a wild-type strain grown in intermediate-phosphate medium and a *PHO4^SA1234WT6^* strain grown in high-phosphate medium have nuclear Pho4, which is predominately phosphorylated on site 6.

To determine whether Pho4 is preferentially phosphorylated on site 6 in intermediate-phosphate medium, we generated phosphopeptide-specific antibodies that recognize phosphorylation on sites 2, 3, and 6 of Pho4. Cells were grown for 2 h in no-, intermediate-, and high-phosphate medium and analyzed by Western blotting, which indicated that there is more unphosphorylated Pho4 present in intermediate-phosphate conditions than in high-phosphate conditions ([Figure 2](#pbio.0000028-g002){ref-type="fig"}E). In high-phosphate medium, when Pho80--Pho85 kinase activity is high, sites 2, 3, and 6 were phosphorylated. In no-phosphate medium, when Pho80--Pho85 kinase activity is low, there was no detectable phosphorylation on sites 2, 3, and 6. In intermediate-phosphate medium, as predicted by in vitro Pho80--Pho85 kinetics, site 6 was phosphorylated, but there was only minimal phosphorylation on sites 2 and 3. Thus, differential phosphorylation of Pho4 occurs in physiologically relevant conditions in vivo and site 6 phosphorylation in vivo correlates with differential gene expression.

Site 6 phosphorylation is lower in intermediate-phosphate medium than high-phosphate medium ([Figure 2](#pbio.0000028-g002){ref-type="fig"}E). Differential expression of *PHO5* and *PHO84* could be the result of differential sensitivity of these two promoters to the amount of unphosphorylated Pho4 in the nucleus. To assess this possibility, we created a Pho4 mutant that behaves as if it were phosphorylated on site 6 constitutively. This was achieved by substitution of the serine at site 6 with aspartate, which hinders the interaction between Pho4 and Pho2 ([@pbio.0000028-Komeili1]). Gene expression in a yeast strain expressing Pho4^WT1234SD6^ was monitored by Northern blotting ([Figure 2](#pbio.0000028-g002){ref-type="fig"}F) and microarray analysis (data not shown). Even when grown in no-phosphate medium, the strain expressing Pho4^WT1234SD6^ exhibited differential expression of *PHO5* and *PHO84*. Therefore, differential expression of *PHO5* and *PHO84* in intermediate-phosphate conditions is not likely to be due to a subset of Pho4 molecules that is unphosphorylated in the nucleus.

Differential Promoter Binding of Pho4 {#s2c}
-------------------------------------

To determine whether differential gene expression results from differential occupancy of Pho4 at *PHO5* and *PHO84*, we examined the binding of Pho4 to these promoters using chromatin immunoprecipitation. There was little enrichment of Pho4 at the *PHO5* or *PHO84* promoters when cells were grown in high-phosphate medium, whereas in no-phosphate medium, Pho4 was significantly enriched at both the *PHO5* and *PHO84* promoters ([Figure 3](#pbio.0000028-g003){ref-type="fig"}B, left). When cells were grown in intermediate-phosphate medium, Pho4 was enriched at the *PHO84* promoter, but was not significantly enriched at the *PHO5* promoter. Furthermore, chromatin immunoprecipitation experiments carried out with *PHO4^SA1234WT6^* and *PHO4^SA1234PA6^* strains grown in high-phosphate medium resembled immunoprecipitations carried out with wild-type cells grown in intermediate and no-phosphate medium, respectively ([Figure 3](#pbio.0000028-g003){ref-type="fig"}B, right). Thus, differential expression of *PHO5* and *PHO84* correlates with differential Pho4 binding to these promoters.

![Deletion of *PHO2* Abrogates Expression of *PHO5* and *PHO84* and Binding of Pho4 to These Promoters\
(A) Quantitation of RNA levels by Northern blot analysis in *pho2Δ* strains grown in no-, intermediate-, or high-phosphate medium.\
(B) Chromatin immunoprecipitation analysis of Pho4. Pho4 was immunoprecipitated from extracts of wild-type cells grown in high-, intermediate-, or no-phosphate medium, from a strain lacking Pho4 and from the two mutant Pho4 strains grown in high-phosphate medium. Experiments using the Pho4^SA1234WT6^- and Pho4^SA1234PA6^-expressing strains are normalized to the maximal amount of enrichment in a strain expressing Pho4^SA1234PA6^ in high-phosphate medium. The fold enrichment of *PHO5* over *ACT1* was 1.03, 0.99, 1.26, 2.84, 2.41, and 5.04 in lanes 1--6, respectively (*pho4Δ*, wt high, wt int, wt no, *PHO4^SA1234WT6^*, and *PHO4^SA1234PA6^*). The fold enrichment of *PHO84* over *ACT1* was 0.99, 1.75, 4.27, 6.28, 10.8, and 11.6 in lanes 1--6, respectively.\
(C) Chromatin immunoprecipitation analysis of Pho4. Pho4 was immunoprecipitated from extracts of wild-type cells grown in no-phosphate medium, a mutant lacking Pho2 in no-phosphate medium, Pho4^SA1234WT6^ and Pho4^SA1234PA6^ strains grown in high-phosphate medium, and *pho2Δ* Pho4^SA1234WT6^ and *pho2Δ* Pho4^SA1234PA6^ strains grown in high-phosphate medium. The fold enrichment of *PHO5* over *ACT1* was 2.84, 1.19, 2.41, 1.49, 5.04, and 2.06 in lanes 1--6, respectively (wt no, *pho2Δ* no, *PHO4^SA1234WT6^*, *pho2Δ PHO4^SA1234WT6^*, *PHO4^SA1234PA6^*, and *pho2ΔPHO4^SA1234PA6^*). The fold enrichment of *PHO84* over *ACT1* was 6.28, 2.0, 10.8, 2.4, 11.6, and 2.63 in lanes 1--6, respectively.](pbio.0000028.g003){#pbio.0000028-g003}

Because site 6 phosphorylation inhibits the Pho4--Pho2 interaction in vitro ([@pbio.0000028-Komeili1]), the preferential induction of genes in intermediate-phosphate medium could be explained if their transcription does not require Pho2. To determine whether the expression of *PHO84* is dependent on Pho2, we deleted *PHO2* in a Pho4 wild-type strain and in strains expressing Pho4^SA1234WT6^ and Pho4^SA1234PA6^. Northern blotting ([Figure 3](#pbio.0000028-g003){ref-type="fig"}A; data not shown) and microarray analysis (data not shown) of these *pho2*Δ strains demonstrated that both *PHO5* and *PHO84* (and the majority of the phosphate-responsive genes) required Pho2 for induction. To determine whether the transcriptional defect in *pho2*Δ strains was due to a defect in binding of Pho4, we used chromatin immunoprecipation to examine Pho4 occupancy at the *PHO5* and *PHO84* promoters in *pho2*Δ strains. Surprisingly, in a *pho2*Δ strain, little Pho4 was bound to the *PHO5* or *PHO84* promoter in either wild-type or mutant Pho4 strain backgrounds ([Figure 3](#pbio.0000028-g003){ref-type="fig"}C) ([@pbio.0000028-Barbaric1]). Therefore, Pho2 must directly or indirectly facilitate Pho4 binding to the *PHO84* promoter, even when Pho4 is phosphorylated on site 6.

Physiological Role of Site 6 Phosphorylation {#s2d}
--------------------------------------------

Site 6 phosphorylation correlates with differential gene expression in wild-type cells and is sufficient to cause differential gene expression in strains expressing Pho4 mutants, but this does not mean site 6 phosphorylation is necessary for differential gene induction. If site 6 phosphorylation is the sole mechanism to inhibit *PHO5* expression in intermediate-phosphate conditions, a strain grown in intermediate-phosphate medium (where Pho4 is nuclear) expressing a mutant Pho4 that cannot be phosphorylated on site 6 should significantly induce *PHO5*. We therefore created a strain expressing a Pho4 mutant, Pho4^WT1234PA6^, that cannot be phosphorylated on site 6 but is able to bind Pho2. Fluorescence microscopy was used to confirm proper localization of this mutant (data not shown). In contrast to expectations, the mutant that prevents site 6 phosphorylation did not strongly influence the expression of *PHO5* or *PHO84* in intermediate-phosphate medium ([Figure 5](#pbio.0000028-g005){ref-type="fig"}A). This suggests that a second mechanism that contributes to differential expression of *PHO5* and *PHO84* expression exists in intermediate-phosphate conditions. Because a Pho4 mutant that is refractory to phosphorylation, *PHO4^SA1234PA6^* (see [Figure 1](#pbio.0000028-g001){ref-type="fig"}C), induces all phosphate-responsive genes, we conclude that this second mechanism is likely to work through Pho4 and Pho80--Pho85.

![A Strain Expressing Pho4^SA14PA6^ from a Low Copy Plasmid Differentially Expresses *PHO5* and *PHO84* in Intermediate-Phosphate Medium\
(A) Fluorescence microscopy of yeast cells containing Pho4^SA14PA6^--GFP grown in no, 100 μM, or 10 mM phosphate medium.\
(B) Quantitation of RNA levels by Northern blot analysis of *PHO84*, *PHO5*, and *ACT1* from strains expressing Pho4^SA14PA6^ or Pho4^WT1234PA6^ from a low copy plasmid grown in no, 100 μM, or 10,000 μM phosphate medium.](pbio.0000028.g005){#pbio.0000028-g005}

Although site 6 phosphorylation is not necessary to inhibit *PHO5* expression, it is necessary to keep cells from inducing transcription of *PHO84* in high-phosphate medium. A strain expressing Pho4^WT1234PA6^ grown in high-phosphate medium had levels of *PHO5* and *PHO84* expression that were similar to those of a wild-type strain grown in intermediate-phosphate medium (see [Figure 4](#pbio.0000028-g004){ref-type="fig"}A). Site 6 phosphorylation was necessary to inhibit binding of Pho4 to the *PHO84* promoter in high-phosphate medium, but was not required to inhibit binding of Pho4 to the *PHO5* promoter in intermediate-phosphate medium (see [Figure 4](#pbio.0000028-g004){ref-type="fig"}B).

![A Strain Expressing Pho4 That Cannot Be Phosphorylated on Site 6 Does Not Induce *PHO5* in Intermediate-Phosphate Medium\
A strain expressing Pho4^WT1234PA6^ grown for 2 h in no-, intermediate-, and high-phosphate medium was analyzed by Northern blot analysis (A) and chromatin immunoprecipitation (B). The fold enrichment of *PHO5* over *ACT1* was 1.71, 2.42, 10.49, 0.99, 1.26, and 2.84 in lanes 1--6, respectively (*PHO4^WT1234WT6^* high, *PHO4^WT1234WT6^* int, *PHO4 ^WT1234WT6^* no, wt high, wt int, wt no). The fold enrichment of *PHO84* over *ACT1* was 24.64, 27.44, 43.74, 1.75, 4.27, and 6.28 in lanes 1--6, respectively.](pbio.0000028.g004){#pbio.0000028-g004}

It is possible that phosphorylation on site 1 or 4 could be contributing to differential expression of *PHO5* and *PHO84*. To assess this possibility, we made a plasmid-expressed version of Pho4, Pho4^SA14PA6^, which can only be phosphorylated on sites 2 and 3. We used fluorescence microscopy to confirm that, in intermediate-phosphate medium, this mutant is localized to the nucleus ([Figure 5](#pbio.0000028-g005){ref-type="fig"}A) (see Supplementary Microscopy Section below). Because this mutant is localized to the cytoplasm in high-phosphate conditions, we infer that this mutant can be phosphorylated on sites 2 and 3 ([Figure 5](#pbio.0000028-g005){ref-type="fig"}A). Pho4^SA14PA6^-expressing strains grown in intermediate-phosphate medium still induce *PHO5* and *PHO84* differentially ([Figure 5](#pbio.0000028-g005){ref-type="fig"}B). This suggests that the second mechanism of inhibition at the *PHO5* promoter does not involve phosphorylation of sites 1 or 4. Because a *PHO4^SA1234PA6^* strain in high-phosphate medium mimics a wild-type strain grown in no-phosphate medium (see [Figure 2](#pbio.0000028-g002){ref-type="fig"}F), it is likely that the second mechanism for differential regulation of *PHO5* and *PHO84* works through sites 2 and 3.

Supplementary Microscopy Section {#s2e}
--------------------------------

To assess whether variations in the nuclear concentration of Pho4 in different mutant backgrounds might affect the expression of *PHO5* and *PHO84*, the levels of Pho4--GFP were quantified by fluorescence microscopy. Nuclear Pho4^SA1234WT6^ was present at 242 ± 5 arbitrary units, and nuclear Pho4^SA1234PA6^ was present at 242 ± 6 arbitrary units. Strains expressing either of these two mutants had FACS profiles indistinguishable from that of a wild-type *PHO4--GFP* strain.

Pho4^SA14PA6^ expressed from a low copy plasmid had a nuclear concentration of 359 ± 13 arbitrary units when grown in intermediate-phosphate medium. Pho4--GFP had a nuclear concentration of 293 ± 7 arbitrary units when grown in no-phosphate medium.

All strains that were directly compared by FACS or microscopy were grown on the same day, to the same cell density, in the same batch of medium (with only phosphate levels varied when appropriate).

Discussion {#s3}
==========

Our results demonstrate that three transcriptional outputs can be generated by a pathway whose regulation is controlled by one kinase, Pho80--Pho85, and one transcription factor, Pho4. Whereas fully phosphorylated Pho4 cannot activate transcription of any of the phosphate-responsive genes and unphosphorylated Pho4 can efficiently activate transcription of all phosphate-responsive genes, partially phosphorylated Pho4 contributes to the activation of some phosphate-responsive genes, but not others. When Pho4 is localized to the nucleus and phosphorylated on site 6, it can efficiently bind to the promoter of *PHO84* and activate its transcription, but it does not efficiently bind to or activate *PHO5*. Our in vitro studies of Pho4 phosphorylation suggested that when Pho80--Pho85 was partially active, Pho4 would accumulate in the nucleus phosphorylated on site 6. In vivo, Pho4 accumulates in the nucleus phosphorylated on site 6 in growth medium containing a range of intermediate-phosphate concentrations, conditions that we anticipate result in partial activity of Pho80--Pho85. Nuclear accumulation of this Pho4 phosphoform correlates with both differential expression of *PHO5* and *PHO84*, as well as with differential binding to the *PHO5* and *PHO84* promoters.

Although nuclear Pho4 phosphorylated on site 6 differentially binds to the *PHO84* and *PHO5* promoters and differentially activates transcription, site 6 phosphorylation is not the only mechanism contributing to differential expression of phosphate-responsive genes in intermediate-phosphate conditions. When we prevent site 6 phosphorylation, we still observe differential expression of *PHO84* and *PHO5* in intermediate-phosphate conditions. We have not yet identified the second mechanism contributing to differential expression, but this mechanism works through Pho80--Pho85-dependent phosphorylation of site 2 and 3 of Pho4. It is possible that this additional mechanism functions redundantly with site 6 phosphorylation to cause differential expression of phosphate-responsive genes.

We propose that differences in the regulation of *PHO5* and *PHO84* are caused by affinity differences and kinetic mechanisms. If the *PHO84* promoter has higher affinity for Pho4 than does the *PHO5* promoter, differential occupancy of these promoters in intermediate-phosphate conditions may lead to differences in transcription ([Figure 6](#pbio.0000028-g006){ref-type="fig"}A). For example, the concentration of Pho4 and its affinity for DNA may be such that in no-phosphate conditions Pho4 binding at the *PHO84* promoter is saturated, but binding at the *PHO5* promoter is not. When Pho4 is phosphorylated on site 6, as in intermediate-phosphate conditions, we expect its affinity for DNA is reduced. This reduced affinity would have a more significant impact on the *PHO5* promoter than on the *PHO84* promoter because the *PHO5* promoter was not saturated for binding. This differential occupancy could account for differences in transcription of these genes in intermediate-phosphate conditions.

![Models for Differential Gene Regulation\
(A) Differential affinity of Pho4 for the *PHO84* and *PHO5* promoters can cause differential gene expression. Simulated curves of the percent occupancy of Pho4 at the *PHO84* and *PHO5* promoters, assuming Michaelian binding. Pho4 was modeled as having a *K*~d~ of 10 at the *PHO84* promoter and of 100 at the *PHO5* promoter. Phosphorylation of Pho4 was simulated as raising the *K*~d~ of Pho4 to 40 at the *PHO84* promoter and to 400 at the *PHO5* promoter. The nuclear concentration of Pho4 was assumed to be 7.5-fold higher in intermediate-phosphate medium than in high-phosphate medium and 10-fold higher in no-phosphate medium than in high-phosphate medium.\
(B) Kinetic diagram of the steps leading to active transcription at the *PHO84* and *PHO5* promoters. Differences in the kinetic mechanisms of activation of *PHO84* and *PHO5* can lead to differential gene expression. Even if promoter occupancy is high at the *PHO5* promoter, if the transcriptional activation step is slow compared to the rate of Pho4 phosphorylation and inactivation, *PHO5* will not be induced.](pbio.0000028.g006){#pbio.0000028-g006}

It is also possible that differences in the kinetic mechanisms leading to transcription of these two genes contribute to differential expression ([Figure 6](#pbio.0000028-g006){ref-type="fig"}B). For example, if Pho4 can be phosphorylated while bound to DNA and this phosphorylation can compete with formation of an active transcription complex, the amount of transcription of a gene will be determined by the ratio of the rate of phosphorylation of Pho4 to the rate of formation of an active transcription complex. If formation of an active transcription complex is slower for *PHO5* than for *PHO84*, in intermediate-phosphate conditions phosphorylation of Pho4 may compete with formation of an active transcription complex at the *PHO5* gene, but not at *PHO84*. This model is plausible, given what is known about the *PHO5* promoter; the promoter is regulated by positioned nucleosomes that need to be "remodeled" in order for the gene to be transcribed ([@pbio.0000028-Almer1]). Chromatin remodeling may represent a slow step in the pathway to transcription that could compete with Pho4 inactivation by phosphorylation on DNA. This mechanism is conceptually similar to kinetic proofreading mechanisms proposed for DNA replication and translation ([@pbio.0000028-Hopfield1]).

Differential gene induction should allow a more finely tuned response to changes in external phosphate concentrations. In high-phosphate conditions, cells can uptake ample phosphate from their environment without inducing any phosphate-dependent genes, so the pathway is not induced. In no-phosphate conditions, regardless of the amount of phosphate transporter at the plasma membrane, it is essential to also scavenge phosphate from the environment. Extracellular phosphatases can liberate inorganic phosphate, which the phosphate transporter can uptake with high affinity. In no-phosphate conditions, it is therefore necessary to induce all the phosphate-responsive genes. In intermediate-phosphate conditions, the concentration of phosphate is near the *K*~m~ of the Pho84 permease ([@pbio.0000028-Bun-Ya1]; [@pbio.0000028-Wykoff1]). Therefore, it is likely the amount of phosphate that a cell can take up is proportional to the level of permease at the plasma membrane. Induction of *PHO84* transcription could help to maintain levels of intracellular phosphate as external levels drop. It is not necessary to secrete extracellular phosphatases at high levels because there is ample inorganic phosphate in the growth medium. An intermediate-phosphate response may thereby allow cells to take up appropriate amounts of phosphate over a wide extracellular concentration range at a minimal energetic cost. Induction of genes involved in phosphate storage and mobilization may also help to buffer the cells from rapid changes in extracellular phosphate and allow the cells time to adjust the level of phosphate permeases at the plasma membrane.

Even though the phosphate regulon involves a single kinase and a single regulated transcription factor, yeast cells can generate multiple programs of gene expression in response to different phosphate levels. Many transcription factors contain multiple phosphorylation sites and may also use differential phosphorylation to respond to different levels of extracellular stimuli with different programs of gene expression. Differential phosphorylation of transcriptional regulators may help generate complex programs of gene expression with only a small set of proteins.

Materials and Methods {#s4}
=====================

 {#s4a}

### Strains and media {#s4a1}

The following pRS306-based plasmids were used in this paper: *PHO4^WT1234PA6--GFP^* (EB1377), *PHO4^SA1234WT6--GFP^* (EB1264), and *PHO4^SA1234PA6--GFP^* (EB1265). These plasmids were integrated into the *PHO4* locus to create EY1471, EY1022, and EY1023, respectively. EY1022 and EY1023 were also crossed to an isogenic *pho2*Δ (EY0337) to make EY0778 and EY0779. The following pRS316-based plasmids were used in this paper: *PHO4^SA14PA6--GFP^*(EB1487), *PHO4^WT1234SD6--GFP^* (EB842), and *PHO4^WT1234PA6--GFP^* (EB0843). These plasmids were transformed into a *pho4Δ* strain (EY0130). *PHO4--GFP* EY0693 was used as the wild-type strain. The concentration of phosphate in the growth medium was controlled by adding phosphate in the form of KH~2~PO~4~to synthetic medium with dextrose (SD) but lacking phosphate ([@pbio.0000028-Huang1]).

### cDNA microarrays {#s4a2}

*PHO4^SA1234WT6^*, *PHO4^SA1234PA6^*, and wild-type (K699) strains were grown in high-phosphate medium (SD with 10 mM phosphate), intermediate-phosphate medium (SD with 100 μM phosphate), or no-phosphate medium (SD with no-phosphate) and were harvested in mid-logarithmic growth. Microarray analysis was performed as described ([@pbio.0000028-Carroll1]). Monofunctional reactive Cy5 (Amersham Biosciences, Little Chalfont, United Kingdom) was used to label reverse-transcribed RNA from the mutant cells, and monofunctional reactive Cy3 was used to label reverse-transcribed RNA from the wild-type cells.

### Microarray analysis {#s4a3}

Phosphate-responsive genes were analyzed as described previously ([@pbio.0000028-Carroll1]). The percent of maximal induction for each transcript was determined from at least two independent microarray datasets. All error bars are standard error. Genes that were reported met the following criteria: (1) induction was at least 2-fold in an experiment, and (2) there was less than a 2-fold difference between the values calculated from two independent microarray experiments. Microarrays can be accessed at Gene Expression Omnibus (GEO) at the National Center for Biotechnology Information (NCBI) database as platform number GPL423--425 and sample numbers GSM9157--GSM9162.

### Fluorescence microscopy {#s4a4}

Images were captured with a TE300 inverted Nikon microscope using Metamorph software (Universal Imaging, Downingtown, Pennsylvania, United States) and a Roper Q57 CCD camera. Cells were washed quickly in no-phosphate medium and then grown for 2 h in media of different phosphate concentrations before visualization.

### Northern blot analysis {#s4a5}

RNA was extracted by standard phenol--chloroform techniques ([@pbio.0000028-Steger1]). Probes to *PHO84*, *PHO5*, and *ACT1* (NP_116614) (the gene encoding actin) were made by random priming from a PCR product of each full-length gene. *PHO84* and *PHO5* signal was normalized to signal from *ACT1*. All experiments were performed at least in triplicate. The reported error is the standard error of the mean. Several phosphate-responsive genes (*PHO5*, *PHO8* \[NP_010769\], *PHO11* \[NP_009434\], and *PHO12* \[NP_012087\]) share large regions of homology. Cross-hybridization leads to similar response profiles, even though the genes probably respond differently.

### Quantitation of extracellular phosphate {#s4a6}

Phosphate in the medium was measured with an acidified ammonium molybdate/malachite green G solution (Sigma, St. Louis, Missouri, United States). No more than 50% of the phosphate was depleted in any experiment.

### Phosphopeptide generation {#s4a7}

Rabbit polyclonal phosphopeptide antibodies were generated (Bethyl Laboratories, Montgomery, Texas, United States) that recognize the following phosphorylated peptides derived from the Pho4 sequence (phosphorylated residues are denoted by square brackets): (1) the peptide containing site 2 is CPRLLY\[S\]PLIHT; (2) site 3 is VPVTI\[S\]PNLVACG; and (3) site 6 is VVASE\[S\]PVIAPCG (Bethyl Laboratories). Antibodies were affinity-purified using the synthetic phosphopeptides. In all cases, there was minimal cross-reactivity with the unphosphorylated peptide.

### Western blot analysis {#s4a8}

Western blotting was performed with standard techniques using enhanced chemiluminescence (Pierce Biotechnology, Rockford, Illinois, United States) for detection.

### Quantitation of Pho4 levels {#s4a9}

The level of expression of different versions of Pho4 was quantitated by FACS (Becton Dickinson LSR II; Becton, Dickinson, and Company, Franklin Lakes, New Jersey, United States). The percent nuclear fluorescence of Pho4 grown in different phosphate conditions was determined by quantitating fluorescent pictures of over 100 cells grown in each phosphate condition.

### Chromatin immunoprecipitation {#s4a10}

The chromatin immunoprecipitation protocol was similar to that previously described ([@pbio.0000028-Strahl-Bolsinger1]). After 2 h of growth, cells were fixed with 1% formaldehyde for 15 min at room temperature and harvested. To obtain DNA, the cell pellet was processed and immunoprecipitated with a polyclonal anti-Pho4 antibody, and copurifying DNA was purified by phenol--chloroform and chloroform extraction. The DNA was then quantified using an Opticon real-time PCR machine (MJ Research, Waltham, Massachusetts, United States) as described previously ([@pbio.0000028-Steger1]). At least three independent extracts were analyzed for each strain and growth condition.

Supporting Information {#s5}
======================

Accession Numbers {#s5a}
-----------------

The GenBank accession numbers of the sequences discussed in this paper are NP_009434, NP_009651, NP_010177, NP_010622, NP_010769, NP_012087, NP_013583, NP_014039, NP_014642, NP_015294, NP_116614, and NP_116692.

Microarrays can be accessed at the Gene Expression Omnibus (GEO) at the National Center for Biotechnlogy Information (NCBI) database as platform number GPL423--425 and sample numbers GSM9157--GSM9162.
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CDK

:   cyclin-dependent kinase

FACS

:   fluorescence-activated cell sorting

GFP

:   green fluorescent protein

SD

:   synthetic medium with dextrose

wt

:   wild-type
